Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
Duster. We need all types of test, but check the 1st May RNS:
"...several key competitive advantages... compared to the liquid, kit-based assays already on market:
... only requires the addition of patient sample, with no other user preparation required...
Integrated controls...
can be transported globally without the need for refrigeration, which will support global product distribution. "
CE mark approval planned by 22 May, but expect athis to be fast-tracked.
80p is below mid price, so it is assumed to be a sell. That's how buys and sells are determined by sites listing trades - they are not known to be buys or sells. Late reported trades can look wrong also because they are always judged against the mid-price at time of printing
There's no shortage of chat. We are all in uncharted waters. The good thing is loads of pharmas are into accelerated Covid-19 projects, so news can come quickly causing sharp rises in SP - just pick one that hasn't had news for a while and wait. I use Google in Chrome with its multi-window extension for free basic live charts and Investegate.co.uk for news (RNS). Halifax offer an online sharedealing ISA, but it is struggling with demand today! Hth.